ILMN Jan 2025 340.000 call
| Previous close | 0.8000 |
| Open | 0.8000 |
| Bid | 0.3500 |
| Ask | 1.8500 |
| Strike | 340.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.8000 - 0.8000 |
| Contract range | N/A |
| Volume | |
| Open interest | 53 |
- GuruFocus.com
Illumina Inc (ILMN) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ...
Despite mixed financial results, Illumina showcases strategic advancements and optimistic future projections in its first quarter of 2024.
ZacksIllumina (ILMN) Reports Q1 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Illumina (ILMN) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ReutersIllumina reaffirms annual revenue forecast over continued sluggish demand
The San Diego, California-based company, whose tools and services are used in developing therapies and vaccines, has seen both a slowdown in demand from key markets such as China and cautious spending from its customers. The gene sequencing machine maker continues to expect revenue growth from its core segment to be roughly flat this year compared with 2023, and still sees its adjusted operating margin to be about 20%. U.S. life sciences Illumina's first-quarter revenue was $1.08 billion, above analysts' estimate of $1.05 billion.
